Imagine battling relentless hallucinations for nearly two decades, trapped in a cycle of fear and helplessness that makes every day feel like a precarious tightrope walk. But what if a groundbreaking talking therapy could rewrite your story, empowering you to regain control? That's the transformative journey of Thom Brandwood-Spencer, and it's sparking hope for countless others grappling with similar struggles.
Thom, now 28, first encountered these false visions as a nine-year-old boy walking home from school. Picture this: he vividly imagined himself leaping between lampposts, a seemingly whimsical start that soon spiraled into something far more unsettling. As he entered his teenage years, those images turned darker and more menacing, evoking a constant sense of impending doom—like eerie warnings of disasters yet to unfold. For beginners trying to grasp this, hallucinations are vivid perceptions of things that aren't really there, such as seeing shapes or hearing voices, and they can be terrifying because your brain treats them as real threats.
Fast-forward to today, and researchers at the University of Sheffield are piloting a promising approach called IMAPS—a specialized form of talking therapy designed specifically for psychosis patients. Psychosis, broadly speaking, is a state where someone disconnects from reality, often through delusional beliefs or hallucinations. It's not uncommon; about three-quarters of those affected experience intrusive mental images that replay like unwanted movies in their minds. Thom was diagnosed with paranoid schizophrenia, a subtype of psychosis that kicked in during his teens with auditory hallucinations (hearing voices) and visions of shadowy, featureless figures that heightened his paranoia.
But here's where it gets controversial: Could this therapy alone really challenge decades of entrenched mental health challenges, or should it always be paired with medication? The IMAPS trial aims to help patients reframe those haunting images by replacing them with more empowering alternatives. For Thom, a 12-week course taught him creative techniques, like envisioning those menacing figures encased in diving suits or armored gear, transforming their perceived threat. He realized the real danger stemmed not from the figures themselves, but from his own internal emotions—a revelation that shattered his sense of vulnerability. 'It felt like they could no longer reach me,' he shared, highlighting how this shift liberated him from the grip of powerlessness.
Dr. Chris Taylor, the clinical psychologist leading the trial, explains why this matters: 'Imagery packs a punch far stronger than words alone when it comes to stirring up feelings.' Take paranoia, for example—suppose you're convinced someone might break into your home to harm you. If that fear manifests as a vivid mental picture, it cranks up your anxiety and paranoia to dangerous levels, making the worry feel all too real. IMAPS addresses this by guiding patients to reshape those images, fostering a sense of agency. And this is the part most people miss: It's not just about dismissing hallucinations; it's about rewriting the emotional narrative attached to them, turning passive suffering into active empowerment.
The team hopes this leads to a comprehensive clinical trial to assess the therapy's cost-effectiveness and real-world impact, potentially making it a standard treatment. For Thom, IMAPS didn't just alleviate symptoms—it separated the images from the overwhelming sense of menace they provoked. 'The hardest part was believing it was all permanent and inescapable,' he reflected. 'This therapy flipped that script, proving I could reclaim my story.' Today, he channels his experiences into a rewarding career in substance use and mental health services, where he provides the support he so desperately needed at the start.
To dive deeper, check out highlights from South Yorkshire on BBC Sounds at https://www.bbc.co.uk/sounds/curation/p0cjdy2n, or catch up with the latest episode of Look North at https://www.bbc.co.uk/programmes/b006mj5m.
What are your thoughts on this? Do you see IMAPS as a game-changer for psychosis treatment, potentially reducing reliance on traditional medications—or is it too simplistic, perhaps overlooking biological factors? Could this empower more people to break free from powerlessness, or might it raise unrealistic expectations? Share your opinions in the comments; let's discuss!
